These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4628582)

  • 21. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
    Benckhuijsen C
    Folia Med Neerl; 1969 Dec; 12(2):74-84. PubMed ID: 4894168
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract]   [Full Text] [Related]  

  • 23. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
    Dubois-Ferrière H; Aguercif M; Hazeghi P; Rudhardt M
    Schweiz Med Wochenschr; 1970 Feb; 100(7):321-3. PubMed ID: 5263342
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytarabine (Alexan) for induction and intermediate therapy of acute leukemia in children and adolescents with special reference to oral administration].
    Oehme J; Reckelkamm E
    Med Welt; 1973 Apr; 24(14):537-8. PubMed ID: 4704282
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetics of 1-beta-D-arabinofuranosylcytosine-induced chromosome breaks.
    Benedict WF; Harris N; Karon M
    Cancer Res; 1970 Oct; 30(10):2477-83. PubMed ID: 5528922
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine.
    Kaplan HG; Appelbaum FR; Cheever MA; Greenberg PD; Wood T; Fefer A
    Cancer Treat Rep; 1982 Jun; 66(6):1397-8. PubMed ID: 7083242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone.
    Grindey GB; Mihich E; Nichol CA
    Cancer Res; 1972 Mar; 32(3):522-6. PubMed ID: 5061306
    [No Abstract]   [Full Text] [Related]  

  • 28. Maintenance management of acute nonlymphocytic leukemia.
    Lewis JP; Pajak TF; Linman JW; Bateman JR
    Cancer Clin Trials; 1981; 4(2):115-24. PubMed ID: 7249249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.
    Adès L; Fenaux P
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):678-82. PubMed ID: 17099625
    [No Abstract]   [Full Text] [Related]  

  • 30. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
    Taverna C; Jacky E; Sauter C
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Mar; 69(3):263-79. PubMed ID: 4846658
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of cytosine arabinoside upon proliferating epithelial cells.
    Verbin RS; Diluiso G; Liang H; Farber E
    Cancer Res; 1972 Jul; 32(7):1476-88. PubMed ID: 5030576
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult].
    Avilés-Miranda A; Monroy-Arellano LM; Conte-Lanza G; Morales-Polanco MR; Pizzuto-Chávez J
    Gac Med Mex; 1980 Aug; 116(8):359-64. PubMed ID: 7002697
    [No Abstract]   [Full Text] [Related]  

  • 34. [A new agent active in the treatment of acute leukemia: cytosine arabinoside].
    Bernard J; Boiron M; Jacquillat C; Weil M; Najean Y
    Presse Med (1893); 1966 Mar; 74(16):799-802. PubMed ID: 5907421
    [No Abstract]   [Full Text] [Related]  

  • 35. [The role of cytarabine in polychemotherapy of leukemia].
    Quaglino D; De Pasquale A; Zanni G
    Haematologica; 1972; 57(7):371-88. PubMed ID: 4628584
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of DNA synthesis but not of poly-dAT synthesis by the arabinose analogue of cytidine in vitro.
    Furlong NB; Gresham C
    Nature; 1971 Oct; 233(5320):212-4. PubMed ID: 5165006
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Management of acute leukemia.
    Freireich EJ; Bodey GP; McCredie KB; Rodriguez V; Hart JS; Burgess MA; Gutterman JU
    Proc Natl Cancer Conf; 1972; 7():345-9. PubMed ID: 4764911
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
    Gibson MH; Bertalanffy FD
    J Natl Cancer Inst; 1972 Oct; 49(4):1007-18. PubMed ID: 5084119
    [No Abstract]   [Full Text] [Related]  

  • 39. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.